Dr. Robert A. Sellards, MD

Dr. Sellards practices at Mark J Powers MD PA Florida Orthopaedic Specialists in Stuart, Florida.

Dr. Sellards' NPI, 1386689164, was assigned on June 17, 2006. Dr. Sellards graduated from Medical College of Georgia in 1995. Dr. Sellards holds Florida license ME97034.

Dr. Sellards' primary practice is Mark J Powers MD PA Florida Orthopaedic Specialists, at 1151 SE Indian St, Stuart, FL 34997 in Martin County. The practice phone is (772) 335-4770.

Dr. Sellards' primary practice is Mark J Powers MD PA Florida Orthopaedic Specialists in Stuart, Florida. Dr. Sellards is also affiliated with Cleveland Clinic Martin North Hospital. The medical group on file is Florida Orthopaedic Specialists. Dmand AI also links Dr. Sellards to 3 more hospitals, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sellards practices, 7 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Sellards' primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Sellards is board certified in orthopaedic sports medicine by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Sellards' licenses on file in 4 states: Florida, Texas, Louisiana and Illinois.

Dmand AI lists arthritis, bursitis, carpal tunnel syndrome, enthesopathy in foot or ankle, hand joint or tendon inflammation, hip replacement, joint pain and knee arthroscopy among the conditions Dr. Sellards treats.

CMS data shows 7,270 Medicare services from Dr. Sellards across 30 procedure codes in 2024, for 811 Medicare patients. Medicare paid $496,382 for them.

CMS counts 811 Medicare patients who saw Dr. Sellards in 2024. The largest group is 75 to 84, with 343 patients. 75% of them have arthritis, and 75% have high blood pressure. 2% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sellards' median patient age at 69, with 57% women.

In 2024, Dr. Sellards wrote 1,127 Medicare Part D claims for 324 patients. 98% of them were for generic drugs. CMS names the drug for 1,041 of them, across 13 drugs with 11 or more claims each, at $5,934 in total drug cost. In 2023, CMS named 749 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Sellards for performance year 2024, reported as part of a group. Dr. Sellards accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 12 procedures of lower limb (leg) arthroscopy (minimally invasive joint repair) by Dr. Sellards, more than 83% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Sellards, published from 2005 to 2006. The most frequent topics are Arthroscopy and Anterior Cruciate Ligament. Dr. Sellards has published most often in Arthroscopy. Dr. Sellards' most frequent co-author is Brian J. Cole, MD.

CMS Open Payments shows 52 general payments to Dr. Sellards from 10 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 81% of the total. Stryker Corporation paid the most, $1,588.

Dmand AI lists 1 award for Dr. Sellards, most recently CMS Stage 1 EHR in 2012.

Dr. Sellards graduated from Medical College of Georgia in 1995.

Dr. Sellards is in network with 10 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.